
    
      PROTOCOL OUTLINE: Patients receive high-dose cyclophosphamide IV on days 1-4 and filgrastim
      (G-CSF) starting on day 10 and continuing until blood counts recover.

      Patients are followed at 1, 3, 6, and 12 months and then annually thereafter.
    
  